Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Smoking status: not checked. AREDS2 Formula: what these mean for you changes depending on whether you smoke or used to, and you have not told us. That check was skipped.
Head-to-head evidence comparison — which supplement is right for you?
AREDS2 Formula vs Vitamin C: Vitamin C has the stronger overall evidence (8 vs 7/10); the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Vitamin C wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Likely helps
8 of 11 studies with measurable effects showed benefit.
Top outcomes
One AREDS2 daily regimen, usually split into two servings: vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc 80 mg (as zinc oxide) and copper 2 mg (as cupric oxide)
With meals
A product matching the AREDS2 composition exactly: vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc 80 mg, copper 2 mg
500-1000mg
With meals, Split doses if taking >500mg
Ascorbic acid or buffered vitamin C
and 3 more not shown
Years — average follow-up was 6.3 years
Years
Long-term
Years
Ongoing
1-2 weeks
4-8 weeks
With high doses (>2g)
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
JAMA (2013) · Rct · n=4203
Primary analysis was NULL: lutein/zeaxanthin HR 0.90 (98.7% CI 0.76-1.07, P=.12); DHA+EPA HR 0.97 (0.82-1.16, P=.70); both together HR 0.89 (0.75-1.06, P=.10)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Arch Ophthalmol (2001) · Rct · n=3640
Antioxidants plus zinc vs placebo for advanced AMD: OR 0.72 (99% CI 0.52-0.98). Zinc alone OR 0.75 (0.55-1.03); antioxidants alone OR 0.80 (0.59-1.09) — neither significant on its own
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
JAMA Ophthalmol (2022) · Cohort · n=3882
10-year lung cancer odds ratio: 1.82 (95% CI 1.06-3.12, P=.02) for beta-carotene assignment vs 1.15 (0.79-1.66, P=.46) for lutein/zeaxanthin
Vitamin C supplementation for prevention and treatment of pneumonia.
The Cochrane database of systematic reviews (2021) · Systematic review · n=2655
Five studies with 2655 participants (2 RCTs, 3 quasi-RCTs). Three included children under five, one school-aged children and one adults.
Vitamin C supplementation in pregnancy
The Cochrane database of systematic reviews (2015) · Meta analysis · n=24300
29 trials involving 24,300 pregnant women.
Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults
Nutrients (2025) · Systematic review
Most studies (77%) had a low risk of bias.
Vitamin C has a higher evidence score (8/10 vs 7/10) and wins in 3 of 3 categories.
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
AREDS2 works for diagnosed AMD; lutein/screen-strain claims are weaker. Who actually benefits.
CoQ10, zinc, selenium, carnitine modestly help sperm parameters — but live-birth evidence is weak.
Zinc timing, vitamin D, the real vitamin C effect — and the elderberry caution.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.